Role of herbal compounds (PC-SPES) in hormone-refractory prostate cancer: Two case reports

被引:36
作者
de la Taille, A [1 ]
Hayek, OR [1 ]
Burchardt, M [1 ]
Burchardt, T [1 ]
Katz, AE [1 ]
机构
[1] Columbia Univ Coll Phys & Surg, Columbia Presbyterian Med Ctr, Dept Urol, Squier Urol Clin, New York, NY 10032 USA
关键词
D O I
10.1089/acm.2000.6.449
中图分类号
R [医药、卫生];
学科分类号
10 ;
摘要
Purpose: Herbal therapies are unconventional treatments that have been used for several different diseases. PC-SPES is an herbal mixture, composed of eight different herbs (chrysanthemum, isatis, licorice, Ganoderma lucidum, Panax pseudo-ginseng, Rabdosia rubescens, saw palmetto, and scutellaria), which has been used as an alternative in the treatment of prostate cancer. We report two cases of hormone-refractory prostate cancer patients, who showed a favorable response to therapy with this herbal combination, controlling the progression of the disease. Methods: We report two cases of biopsy proven prostate cancer patients with metastatic disease, treated with total androgen blockade, progressing to an androgen-independent status. These patients were offered traditional therapies for hormone-resistant prostate cancer, and they chose to take PC-SPES. The follow-up as well as their evolution are described. Results: PC-SPES extract decreased the prostate-specific antigen (PSA) value for both patients from an initial value of 100 and 386 ng/mL to 24 and 114 ng/mL after 1 year and 4 months, respectively, remaining stable until now. No gynecomastia or hot flashes were observed in these patients and the treatment was well tolerated. Conclusion: PC-SPES has shown a strong estrogenic in vitro and in vivo activity as an alternative tool in the management of prostate cancer patients. These cases suggest that PC-SPES might have some potential activity against hormone-independent prostate cancers.
引用
收藏
页码:449 / 451
页数:3
相关论文
共 7 条
[1]  
de la Taille A, 1999, BJU INT, V84, P845
[2]   Clinical and biologic activity of an estrogenic herbal combination (PC-SPES) in prostate cancer [J].
DiPaola, RS ;
Zhang, HY ;
Lambert, GH ;
Meeker, R ;
Licitra, E ;
Rafi, MM ;
Zhu, BT ;
Spaulding, H ;
Goodin, S ;
Toledano, MB ;
Hait, WN ;
Gallo, MA .
NEW ENGLAND JOURNAL OF MEDICINE, 1998, 339 (12) :785-791
[3]   UNCONVENTIONAL MEDICINE IN THE UNITED-STATES - PREVALENCE, COSTS, AND PATTERNS OF USE [J].
EISENBERG, DM ;
KESSLER, RC ;
FOSTER, C ;
NORLOCK, FE ;
CALKINS, DR ;
DELBANCO, TL .
NEW ENGLAND JOURNAL OF MEDICINE, 1993, 328 (04) :246-252
[4]   Trends in alternative medicine use in the United States, 1990-1997 - Results of a follow-up national survey [J].
Eisenberg, DM ;
Davis, RB ;
Ettner, SL ;
Appel, S ;
Wilkey, S ;
van Rompay, M ;
Kessler, RC .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1998, 280 (18) :1569-1575
[5]  
FAN S, 1995, Patent No. 5417979
[6]  
KAMEDA H, 1999, P AN M AM SOC CLIN, V18, pA320
[7]   Cancer statistics, 1999 [J].
Landis, SH ;
Murray, T ;
Bolden, S ;
Wingo, PA .
CA-A CANCER JOURNAL FOR CLINICIANS, 1999, 49 (01) :8-31